Updated Jul 16, 2026
Holmlin R. Erik is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Erik R. Holmlin is a prominent executive in the biotechnology sector, currently serving as the CEO of Bionano Genomics, Inc., a company focused on genome analysis and molecular diagnostics. He has a strong background in business development and management within the life sciences industry.
| Role | Insider |
|---|---|
| Notability | 75/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-18 | BNGO | Bionano Genomics, Inc. | F — Tax withholding / forfeiture | 51 | $1.10 | $56 |
Erik R. Holmlin is a prominent executive in the biotechnology sector, currently serving as the CEO of Bionano Genomics, Inc., a company focused on genome analysis and molecular diagnostics. He has a strong background in business development and management within the life sciences industry.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Holmlin R. Erik profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.